美国与印度重申加强禁毒合作 聚焦情报共享与前体化学品管控
华盛顿 — 白宫国家药物管制政策办公室（ONDCP）11月10日发布声明说，美国与印度在新德里举行第二届美印药物政策执行工作组会议，双方重申加强双边禁毒合作，重点包括情报共享、协调执法、前体化学品管控、药品供应链完整与减少药物需求。会议于11月2日至3日由印度内政部下属的麻醉品管制局（NCB）主办。
美方代表团由国家药物管制政策办公室代理副主任 Debbie Seguin 率领，印方代表团由麻醉品管制局局长 Anurag Garg 率领。白宫声明说，双方依据美印药物政策框架的职权范围，回顾了打击非法药物贩运的双边合作，并商定上述优先领域。
Anurag Garg 在开幕讲话中介绍了印度2026至2029年愿景路线图。声明说，该路线图强调以网络为中心的调查、前体化学品管控、金融调查、预防与康复，目标是打击贩毒网络的整个生态，包括其资助者、供应者、协助者与物流网络。
国家药物管制政策办公室主任 Sara Carter 说，美印执行工作组与双边合作对扰乱跨国贩毒网络、防止合成药物与化学前体流入全球市场至关重要。她说，在特朗普总统的2026年国家药物管制战略下，美方认识到相关犯罪网络与外国恐怖组织如今像复杂的跨国物流企业一样运作，美方的策略必须同样有针对性，与伙伴跨越国界合作，守住它们所利用的商业供应链。
美国驻印度大使 Sergio Gor 说，特朗普总统的立场很明确，保护民众要从守住边境、在源头切断非法药物网络做起。他说，美印两国不只是谈合作，还在取得实际执法成果，包括堵住非法前体化学品、守住商业供应链、打击利用这些供应链的贩毒集团。
声明说，两国在2026年1月于华盛顿举行的首届执行工作组会议基础上继续推进，讨论了当前贩毒趋势与新出现的威胁，并肯定了执法与监管层面的联合与各自举措，包括 Operation MedMax、Operation WIPE，以及印度为防止用于制造合成药物的前体化学品被挪用而推出的自愿行为准则。双方同意在有针对性的执法议题上进一步分享最佳做法。
白宫声明说，国家药物管制政策办公室负责领导与协调美国的药物政策，制定并落实总统的国家药物管制战略，并通过相关计划支持各地社区。
（来源：白宫）
United States and India Reaffirm Counter-Narcotics Cooperation, Focusing on Intelligence Sharing and Precursor Controls
WASHINGTON — The White House Office of National Drug Control Policy (ONDCP) said in a statement on November 10 that the United States and India held the second India-U.S. Drug Policy Executive Working Group Meeting in New Delhi, where the two sides reaffirmed their commitment to strengthen bilateral counter-narcotics cooperation, with priorities including intelligence sharing, coordinated law enforcement action, precursor control, pharmaceutical supply chain integrity and drug demand reduction. The meeting, held on November 2-3, was hosted by India's Narcotics Control Bureau (NCB), part of the Ministry of Home Affairs.
The U.S. delegation was headed by Debbie Seguin, Acting Deputy Director of ONDCP, and the Indian delegation was led by Anurag Garg, Director General of the NCB. Pursuant to the terms of reference of the U.S.-India Drug Policy Framework, the meeting reviewed bilateral cooperation in combating illicit drug trafficking and identified the priority areas above, the White House statement said.
In his opening remarks, Anurag Garg highlighted India's Vision Roadmap 2026-2029. The statement said the roadmap outlines a comprehensive strategy emphasizing network-centric investigations, precursor control, financial investigations, prevention and rehabilitation, aimed at dismantling drug trafficking networks by targeting their entire ecosystem, including financiers, suppliers, facilitators and logistical networks.
ONDCP Director Sara Carter said the Executive Working Group and bilateral cooperation between the United States and India are vital to disrupting transnational drug trafficking networks and preventing the diversion of synthetic drugs and chemical precursors into global markets. She said that under President Trump's 2026 National Drug Control Strategy, the criminal networks and foreign terrorist organizations faced today operate like sophisticated, multinational logistics enterprises, and that the strategy must be equally targeted, partnering across borders to secure the commercial supply chains they exploit.
U.S. Ambassador to India Sergio Gor said President Trump has been clear that protecting the American people starts with securing the borders and cutting off illicit drug networks at the source. He said India and the United States are delivering real operational results, including choking off illicit precursor chemicals, securing commercial supply chains and dismantling the cartels that exploit them.
The statement said the two sides built on the progress of the first Executive Working Group meeting, held in Washington, D.C., in January 2026, discussed current drug trafficking trends and emerging threats, and welcomed joint and national initiatives at the operational and regulatory levels, including Operation MedMax, Operation WIPE and India's Voluntary Code of Conduct to prevent the diversion of precursor chemicals used to make synthetic drugs. Both sides agreed to further sharing of best practices in targeted law enforcement topics.
The White House statement said ONDCP leads and coordinates U.S. drug policy, develops and implements the President's National Drug Control Strategy, and supports communities through its programs.
(Source: The White House)
来源：白宫
发布：GSM·美国（发布链接）
图片来源：图：白宫大楼（GSM 固定图库）。 / Photo: The White House (GSM asset library).
GSM Global · 本篇英文版 English edition of this story
